1. Global HIV‐1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. (April 2015) Authors: Baxter, JD; Dunn, D; White, E; Sharma, S; Geretti, AM; Kozal, MJ; Johnson, MA; Jacoby, S; Llibre, JM; Lundgren, J Journal: HIV medicine Issue: Volume 16(2015)Supplement 1 Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Transmitted HIV‐1 drug resistance in a large international cohort using next‐generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study. Issue 5 (25th December 2020) Authors: Baxter, JD; Dunn, D; Tostevin, A; Marvig, RL; Bennedbæk, M; Cozzi‐Lepri, A; Sharma, S; Kozal, MJ; Gompels, M; Pinto, AN; Lundgren, J Journal: HIV medicine Issue: Volume 22:Issue 5(2021) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗